HealthEx
Your connected health history, working for you.
San Francisco, United States · Founded 2022
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2022
- Business Model
- B2C
- Website
- healthex.io
- Last Round
- Series AOct 2024
- Rounds
- 2
About
HealthEx is a consumer-driven health data platform that unifies medical records across doctors, clinics, and labs into a single connected health history. Built on federal TEFCA standards and HIPAA-compliant infrastructure, HealthEx covers more than 80% of U.S. care providers and enables patients to securely share their records with providers, health plans, health apps, and AI agents. The company has partnered with Microsoft to integrate consumer health records into Copilot Health, and is backed by General Catalyst and Electric Capital. Founded in 2022, HealthEx is based in San Francisco.
Summary
HealthEx is a Life Sciences company based in San Francisco, United States, founded in 2022. Its most recent funding was a Series A round in Oct 2024. Investors include General Catalyst and Electric Capital.
Tech & App Stack
2 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Oct 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.

Alphabet-backed biotechnology company researching biology of aging and developing interventions t...

Healthcare governance, risk, and compliance software provider helping organizations improve patie...

PHC is a leading provider of diabetes monitoring systems, specialized laboratory equipment, and c...
BridgeBio makes targeted treatments for genetic diseases.
